Effect of BM-MSCs on Chronic AMR After Kidney Transplantation

NCT02563340 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Kidney Transplantation

Interventions

OTHER: BM-MSCs
OTHER: Desensitization therapy (PP, IVIG, rituximab or Bortezomib)

Sponsor

First Affiliated Hospital, Sun Yat-Sen University

Collaborators

[object Object]